Institutional Fund
Psp Research LLC
Las Vegas, NVCIK 21069392 filings on record
Portfolio Value
$141.33M
Q1 2026
Holdings
79
Reported positions
New Buys
21
Opened this quarter
QoQ Change
+23.5%
from $114.42M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Ishares Tr49.9%
- Spdr Series Trust25.7%
- Sera Prognostics Inc3.4%
- Definium Therapeutics Inc0.5%
- Tyra Biosciences Inc0.4%
- Ascendis Pharma A/S0.4%
- Other19.6%
Portfolio Holdings
79 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Ishares Tr | 700.0K | $70.46M | 49.9% | 0 | Held |
| 2 | Spdr Series Trust | 284.9K | $36.39M | 25.7% | +284.9K | New |
| 3 | Sera Prognostics Inc | 2.40M | $4.87M | 3.4% | +2.40M | New |
| 4 | Definium Therapeutics Inc | 34.8K | $657.7K | 0.5% | +34.8K | New |
| 5 | Tyra Biosciences Inc | 16.0K | $612.8K | 0.4% | −5.9K | Reduced |
| 6 | Ascendis Pharma A/S | 2.5K | $571.8K | 0.4% | −79 | Reduced |
| 7 | Pharvaris N V | 20.0K | $565.0K | 0.4% | −511 | Reduced |
| 8 | Cytokinetics Inc | 8.3K | $547.1K | 0.4% | −13 | Reduced |
| 9 | Royalty Pharma PLC | 11.0K | $527.7K | 0.4% | −2.8K | Reduced |
| 10 | Kymera Therapeutics Inc | 6.3K | $524.7K | 0.4% | −48 | Reduced |
69 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio